- Home
- FHTX vs CHPT Comparison
FHTX vs CHPT Comparison
Compare FHTX & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | CHPT |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.4M | 143.0M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FHTX | CHPT |
|---|---|---|
| Price | $1.92 | $8.27 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | $6.00 | ★ $7.50 |
| AVG Volume (30 Days) | 1.0M | ★ 1.3M |
| Earning Date | 11-04-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.32 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $30,909,000.00 | ★ $411,224,000.00 |
| Revenue This Year | N/A | $7.92 |
| Revenue Next Year | $15.98 | $13.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.75 | N/A |
| 52 Week Low | $1.79 | $4.44 |
| 52 Week High | $7.61 | $12.61 |
Technical Indicators
Market Signals| Indicator | FHTX | CHPT |
|---|---|---|
| Relative Strength Index (RSI) | 15.14 | 47.08 |
| Support Level | N/A | $5.39 |
| Resistance Level | $5.35 | $8.47 |
| Average True Range (ATR) | 0.30 | 0.65 |
| MACD | -0.16 | -0.25 |
| Stochastic Oscillator | 5.53 | 9.01 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.